Sara M. Tolaney

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 3%percentile

1.6Author DataRank

Indexed papers

5in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 5 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

A multi-modal single-cell and spatial expression map of metastatic breast cancer biopsies across clinicopathological features

Nature Medicine(2024)10.1038/s41591-024-03215-z

Top 15%

1.3DataRank

Top 15%91 citations

Daniel L. Abravanel, Åsa Segerstolpe, Timothy R. Blosser, Yury Goltsev, Yi Cui +57 more

Papers

Driven by 42 papers — median percentile 0. Top paper: “Sacituzumab govitecan in previously treated hormone receptor-positive/HER2-negative metastatic breast cancer: final results from a phase I/II, single-arm, basket trial”.

Sacituzumab govitecan in previously treated hormone receptor-positive/HER2-negative metastatic breast cancer: final results from a phase I/II, single-arm, basket trial

Annals of Oncology(2020)10.1016/j.annonc.2020.09.004

N/A

5.0DataRank · unranked

145 citations

Jennifer R. Diamond, Linda T. Vahdat, Sara M. Tolaney, Dejan Juric, Joyce O’Shaughnessy +11 more

Massively parallel enrichment of low-frequency alleles enables duplex sequencing at low depth

Nature Biomedical Engineering(2022)10.1038/s41551-022-00855-9

N/A

2.2DataRank · unranked

83 citations

Erica Nguyen, Jin H. Bae, Timothy Blewett, Justin Rhoades, Sarah C. Reed +15 more

Molecular correlates of response to eribulin and pembrolizumab in hormone receptor-positive metastatic breast cancer

Nature Communications(2021)10.1038/s41467-021-25769-z

N/A

1.8DataRank · unranked

48 citations

Jennifer L. Guerriero, Romualdo Barroso‐Sousa, Tianyu Li, Tess A. O’Meara, Anita Giobbie‐Hurder +24 more

Pembrolizumab in brain metastases of diverse histologies: phase 2 trial results

Nature Medicine(2023)10.1038/s41591-023-02392-7

N/A

1.6DataRank · unranked

66 citations

Albert E. Kim, Anita Giobbie‐Hurder, Eudocia Q. Lee, Nancy U. Lin, Beth Overmoyer +28 more

A multi-modal single-cell and spatial expression map of metastatic breast cancer biopsies across clinicopathological features

Nature Medicine(2024)10.1038/s41591-024-03215-z

Top 15%

1.3DataRank

Top 15%91 citations

Daniel L. Abravanel, Åsa Segerstolpe, Timothy R. Blosser, Yury Goltsev, Yi Cui +57 more

Phase Ib study of pembrolizumab in combination with trastuzumab emtansine for metastatic HER2-positive breast cancer

Journal for ImmunoTherapy of Cancer(2022)10.1136/jitc-2022-005119

N/A

1.2DataRank · unranked

39 citations

Tanya E. Keenan, Tianyu Li, Nabihah Tayob, Gerburg M. Wulf, Edward T. Richardson +10 more

Clinical Efficacy and Whole-Exome Sequencing of Liquid Biopsies in a Phase IB/II Study of Bazedoxifene and Palbociclib in Advanced Hormone Receptor–Positive Breast Cancer

Clinical Cancer Research(2022)10.1158/1078-0432.ccr-22-2305

N/A

0.918DataRank · unranked

28 citations

Tianyu Li, Albert Grinshpun, Tim H. H. Coorens, Douglas Russo, Leilani Anderson +16 more

Endocrine Therapy Synergizes with SMAC Mimetics to Potentiate Antigen Presentation and Tumor Regression in Hormone Receptor–Positive Breast Cancer

Cancer Research(2023)10.1158/0008-5472.can-23-1711

N/A

0.596DataRank · unranked

15 citations

Yingtian Xie, Shira Sherman, Zsuzsanna Nagy, Douglas Russo, Tara Akhshi +36 more

Abnormal vascular structure and function within brain metastases is linked to pembrolizumab resistance

Neuro-Oncology(2023)10.1093/neuonc/noad236

N/A

0.323DataRank · unranked

6 citations

Kevin W Lou, Anita Giobbie‐Hurder, Ken Chang, Mishka Gidwani, Katharina Hoebel +38 more

MAESTRO affords ‘breadth and depth’ for mutation testing

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.01.22.427323

N/A

0.314DataRank · unranked

5 citations

Erica Nguyen, Jin H. Bae, Justin Rhoades, Sarah C. Reed, Douglas Shea +15 more

Molecular characterization of HER2-negative breast cancers reveals a distinct patient subgroup with 17q12 deletion and heterozygous loss of ERBB2

ESMO Open(2025)10.1016/j.esmoop.2024.104111

N/A

0.282DataRank · unranked

5 citations

P. Tarantino, Rong Li, Albert Grinshpun, Hersh Gupta, Melissa E. Hughes +12 more

Clinical characteristics, racial inequities, and outcomes in patients with breast cancer and COVID-19: A COVID-19 and cancer consortium (CCC19) cohort study

eLife(2023)10.7554/elife.82618

Top 58%

0.271DataRank

Top 58%3 citations

Shaveta Vinayak, Ali Raza Khaki, Tianyi Sun, Nicole M. Kuderer, David M. Aboulafia +92 more

The effects of a clinic‐based weight loss program on health‐related quality of life and weight maintenance in cancer survivors: A randomized controlled trial

Psycho-Oncology(2021)10.1002/pon.5817

N/A

0.204DataRank · unranked

2 citations

Anita Giobbie‐Hurder, Rachel L. Yung, Erica L. Mayer, Sara M. Tolaney, Ann H. Partridge +2 more

Author Correction: A multi-modal single-cell and spatial expression map of metastatic breast cancer biopsies across clinicopathological features

Nature Medicine(2025)10.1038/s41591-025-03665-z

N/A

0.104DataRank · unranked

1 citations

Daniel L. Abravanel, Åsa Segerstolpe, Timothy R. Blosser, Yury Goltsev, Yi Cui +57 more

Clinical Characteristics, Racial Inequities, and Outcomes in Patients with Breast Cancer and COVID-19: A COVID-19 and Cancer Consortium (CCC19) Cohort Study

The Medicine Forum(2023)10.1101/2023.03.09.23287038

Top 100%

0DataRank

Top 100%0 citations

Shaveta Vinayak, Ali Raza Khaki, Tianyi Sun, Nicole M. Kuderer, David M. Aboulafia +92 more

Data from Clinical Efficacy and Molecular Response Correlates of the WEE1 Inhibitor Adavosertib Combined with Cisplatin in Patients with Metastatic Triple-Negative Breast Cancer

(2023)10.1158/1078-0432.c.6530060.v1

Top 100%

0DataRank

Top 100%0 citations

Tianyu Li, Tuulia Vallius, Jennifer L. Guerriero, Nabihah Tayob, Bose Kochupurakkal +17 more

Data from Clinical Efficacy and Molecular Response Correlates of the WEE1 Inhibitor Adavosertib Combined with Cisplatin in Patients with Metastatic Triple-Negative Breast Cancer

(2023)10.1158/1078-0432.c.6530060

Top 100%

0DataRank

Top 100%0 citations

Tianyu Li, Tuulia Vallius, Jennifer L. Guerriero, Nabihah Tayob, Bose Kochupurakkal +17 more

Data from Effect of Exercise or Metformin on Biomarkers of Inflammation in Breast and Colorectal Cancer: A Randomized Trial

(2023)10.1158/1940-6207.c.6547643.v1

N/A

0DataRank · unranked

0 citations

Sui Zhang, Jennifer A. Ligibel, MELINDA L. IRWIN, Lee W. Jones, Nancy Campbell +14 more

Structural and functional vascular dysfunction within brain metastases is linked to pembrolizumab inefficacy

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.08.25.554868

N/A

0DataRank · unranked

0 citations

Kevin W Lou, Anita Giobbie‐Hurder, Ken Chang, Mishka Gidwani, Katharina Hoebel +38 more

896 Characterizing macrophage heterogeneity in HR+/HER2- metastatic breast cancer reveals novel mechanisms of resistance

Regular and Young Investigator Award Abstracts(2023)10.1136/jitc-2023-sitc2023.0896

N/A

0DataRank · unranked

0 citations

Kenichi Shimada, Madeline G Townsend, Tianyu Li, Nabihah Tayob, Molly DiLullo +9 more

Prognostic value of HER2DX in early-stage HER2-positive breast cancer: a comprehensive analysis of 757 patients in the Sweden Cancerome Analysis Network—Breast dataset (SCAN-B)

ESMO Open(2024)10.1016/j.esmoop.2024.102388

N/A

0DataRank · unranked

18 citations

Tomás Pascual, Fara Brasó‐Maristany, Laia Paré, Olga Martínez‐Sáez, Javier Cortés +15 more

Clinical outcomes of early-stage triple-negative breast cancer after neoadjuvant chemotherapy according to HER2-low status☆

ESMO Open(2024)10.1016/j.esmoop.2024.103973

N/A

0DataRank · unranked

12 citations

Danielle Brandes Zakon, Qingchun Jin, Ava Strahan, Melissa Grimm, Melissa E. Hughes +15 more

Qualification of a multiplexed tissue imaging assay and detection of novel patterns of HER2 heterogeneity in breast cancer

npj Breast Cancer(2024)10.1038/s41523-023-00605-3

N/A

0DataRank · unranked

10 citations

Jia‐Ren Lin, Ricardo Pastorello, Ziming Du, Yu-An Chen, Madeline G Townsend +17 more

Phase I study of ribociclib (CDK4/6 inhibitor) with spartalizumab (PD-1 inhibitor) with and without fulvestrant in metastatic hormone receptor-positive breast cancer or advanced ovarian cancer

Journal for ImmunoTherapy of Cancer(2025)10.1136/jitc-2024-010430

N/A

0DataRank · unranked

14 citations

Noah Graham, Lestat R. Ali, Christina I. Herold, Jennifer Desrosiers, Khanh Do +13 more

Cellular reprogramming during anti-PD-1 and chemotherapy treatment in early-stage primary hormone receptor-positive breast cancer

Nature Communications(2025)10.1038/s41467-025-66659-y

N/A

0DataRank · unranked

2 citations

Adrienne G. Waks, Erica Pimenta, Breanna Titchen, Kevin Bi, Sabrina Y. Camp +16 more

A Randomized Phase 2 Study of Neratinib With or Without Fulvestrant for Patients With HER2-Positive, Estrogen Receptor-Positive Metastatic Breast Cancer

Clinical Breast Cancer(2025)10.1016/j.clbc.2025.05.009

N/A

0DataRank · unranked

0 citations

Xiangying Chu, Tarah J. Ballinger, Nisha Unni, Sarah Sinclair, Robert Wesolowski +9 more

AXALAP: Phase Ib study of axatilimab in combination with olaparib in BRCA1/2 and PALB2 -associated metastatic HER2-negative breast cancer (BC).

Journal of Clinical Oncology(2025)10.1200/jco.2025.43.16_suppl.tps1143

N/A

0DataRank · unranked

0 citations

Adela Rodríguez Hernandez, Siddhartha Yadav, Ryan Buehler, Grace Augdahl, Tasnim Rahman +9 more

Integration of Gene Expression and Digital Histology to Predict Treatment-Specific Responses in Breast Cancer

medRxiv(2025)10.1101/2025.08.25.25334393

N/A

0DataRank · unranked

0 citations

James M. Dolezal, Hanna M. Hieromnimon, Sara J. Venters, Sara Kochanny, Anran Li +31 more

1270 APOE tumor-associated macrophages and CD4-DOCK4 T cells reveal distinct microenvironmental features in HER2-Low and HER2–0 hormone receptor-positive breast cancer

Regular and Young Investigator Award Abstracts(2025)10.1136/jitc-2025-sitc2025.1270

N/A

0DataRank · unranked

0 citations

Daniel Michaud, Kenichi Shimada, Adam Nelson, Jingxin Fu, Stuart J. Schnitt +7 more

Reversion and non-reversion mechanisms of resistance to PARP inhibitor or platinum chemotherapy in BRCA1/2-mutant metastatic breast cancer

Annals of Oncology(2020)10.1016/j.annonc.2020.02.008

N/A

0DataRank · unranked

157 citations

Ofir Cohen, Bose Kochupurakkal, D. Kim, Connor E. Dunn, Jorge Buendia +20 more

Changes in Peripheral and Local Tumor Immunity after Neoadjuvant Chemotherapy Reshape Clinical Outcomes in Patients with Breast Cancer

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-19-3685

N/A

0DataRank · unranked

60 citations

Mellissa J. Nixon, Paula I. González-Ericsson, Riley E. Bergman, Mark A. Pilkinton, Wyatt J. McDonnell +21 more

Clinical Efficacy and Molecular Response Correlates of the WEE1 Inhibitor Adavosertib Combined with Cisplatin in Patients with Metastatic Triple-Negative Breast Cancer

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-20-3089

N/A

0DataRank · unranked

51 citations

Tianyu Li, Tuulia Vallius, Jennifer L. Guerriero, Nabihah Tayob, Bose Kochupurakkal +17 more

DeepNeuro: an open-source deep learning toolbox for neuroimaging

Neuroinformatics(2020)10.1007/s12021-020-09477-5

N/A

0DataRank · unranked

3 citations

James M. Brown, Ken Chang, Katharina Hoebel, Jay Patel, Bruce R. Rosen +6 more

Chemotherapy-related amenorrhea after adjuvant paclitaxel–trastuzumab (APT trial)

UNC Libraries(2020)10.17615/e33z-ag80

N/A

0DataRank · unranked

0 citations

Harold J. Burstein, Lisa A. Carey, Antonio C. Wolff, Sara M. Tolaney, P. Kelly Marcom +15 more

Inhibition of CDK4/6 Promotes CD8 T-cell Memory Formation

Cancer Discovery(2021)10.1158/2159-8290.cd-20-1540

N/A

0DataRank · unranked

125 citations

Lestat R. Ali, Eleanor Clancy-Thompson, Li Qiang, Katherine S. Ventre, Patrick Lenehan +19 more

Nivolumab in combination with cabozantinib for metastatic triple-negative breast cancer: a phase II and biomarker study

npj Breast Cancer(2021)10.1038/s41523-021-00287-9

N/A

0DataRank · unranked

51 citations

Tanya E. Keenan, Tianyu Li, Nabihah Tayob, Lorenzo Trippa, Ricardo Pastorello +11 more

The Effects of Diabetes and Glycemic Control on Cancer Outcomes in Individuals With Metastatic Breast Cancer

The Journal of Clinical Endocrinology & Metabolism(2022)10.1210/clinem/dgac375

N/A

0DataRank · unranked

16 citations

Melissa E. Hughes, Julia C. Harrod, Janet Files, Greg Kirkner, Lauren Buckley +5 more

Liquid biopsy epigenomic profiling for cancer subtyping

Nature Medicine(2023)10.1038/s41591-023-02605-z

N/A

0DataRank · unranked

121 citations

Ji-Heui Seo, Matthew P. Davidsohn, Brad Fortunato, Karl Semaan, Shahabbedin Sotudian +38 more

PD-1 blockade and CDK4/6 inhibition augment nonoverlapping features of T cell activation in cancer

The Journal of Experimental Medicine(2023)10.1084/jem.20220729

N/A

0DataRank · unranked

34 citations

Ana C. Garrido-Castro, Patrick J. Lenehan, Naïma Böllenrücher, Courtney T. Stump, Michael Dougan +5 more

Nodal positivity and systemic therapy among patients with clinical T1–T2N0 human epidermal growth factor receptor‐positive breast cancer: Results from two international cohorts

Cancer(2023)10.1002/cncr.34750

N/A

0DataRank · unranked

15 citations

Olga Martínez‐Sáez, Adrienne G. Waks, Alison Laws, Monica McGrath, Paolo Tarantino +11 more

Advancing equitable and personalized cancer care: Novel applications and priorities of artificial intelligence for fairness and inclusivity in the patient care workflow

European Journal of Cancer(2023)10.1016/j.ejca.2023.113504

N/A

0DataRank · unranked

11 citations

Chiara Corti, Edward Christopher Dee, Lucas McCullum, Laura Boldrini, Ilana Schlam +5 more

Associations between KIR/KIR-ligand genotypes and clinical outcome for patients with advanced solid tumors receiving BEMPEG plus nivolumab combination therapy in the PIVOT-02 trial

Cancer Immunology Immunotherapy(2023)10.1007/s00262-023-03383-w

N/A

0DataRank · unranked

4 citations

Amy K. Erbe, Jennifer Birstler, KyungMann Kim, Ute Hoch, Sue Currie +8 more

Sara M. Tolaney

Indexed papers

Top data-sharing exemplar

Papers